GH Axis & Metabolic
What Is Sermorelin and Why Does It Have More Human Data Than Most Research Peptides?
Sermorelin (GHRH 1-29) is a synthetic analog of growth hormone-releasing hormone consisting of the first 29 amino acids of endogenous GHRH. It is the shortest synthetic fragment of GHRH that retains full biological activity of the parent molecule, meaning it activates GHRH receptors in the anterior pituitary with the same downstream effect as the full 44-amino-acid endogenous hormone.
The Role of Tesamorelin in Modulating Growth Hormone Pathways and Metabolism
Tesamorelin, a growth hormone-releasing hormone analog, is studied for its effects on lipid metabolism, endocrine function, and cellular energy regulation under controlled research conditions.
Inside the Science of GLP-3: How Retatrutide Is Shaping Metabolic Innovation
GLP-3 peptide (retatrutide) is studied for its impact on metabolic signaling, glucose regulation, and energy balance. Discover how scientists are exploring this next-generation incretin analog.
CJC-1295 and Ipamorelin: Exploring the Research Behind the Growth Hormone Peptide Combination
CJC-1295 and Ipamorelin, two synthetic peptides, are researched for their combined influence on growth hormone release. This article reviews their science and compliance standards.
AOD-9604: Research Overview of the Growth Hormone Fragment 176-191
All content on this page is intended for educational and research purposes only. AOD-9604 is not approved by the FDA for human use and ...